Orexo AB carries a market capitalization of 855.34M, placing it among publicly traded companies globally. Its enterprise value stands at 382.21M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 855.34M |
| Enterprise Value | 382.21M |
Orexo AB currently has 35.13M shares outstanding.
| Shares Outstanding | 35.13M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Orexo AB trades at a trailing price-to-earnings ratio of 1.38.
| PE Ratio | 1.38 |
| PS Ratio | 6.02 |
| PB Ratio | N/A |
| P/TBV Ratio | 2.09 |
| P/FCF Ratio | -14.31 |
| P/OCF Ratio | -13.22 |
| EV / Sales | 3.02 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 78.47 |
Orexo AB maintains a current ratio of 2.03, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.92, indicating elevated leverage, while an interest coverage ratio of -16.36 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.03 |
| Quick Ratio | 1.64 |
| Debt / Equity | 1.92 |
| Debt / EBITDA | -0.04 |
| Interest Coverage | -16.36 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 96.74 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.64 |
| Income Tax | 7.00M |
| Effective Tax Rate | N/A |
Orexo AB's stock has gained approximately 21.44638% over the past 52 weeks. The 50-day moving average sits at 20.41, while the 200-day moving average is 26.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | 21.44638% |
| 50-Day Moving Average | 20.41 |
| 200-Day Moving Average | 26.03 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Orexo AB generated 126.50M in revenue and converted that into 551.10M in net income, yielding earnings per share of -6.92. EBITDA reached -199.60M, while operating income came in at -199.60M.
| Revenue | 126.50M |
| Gross Profit | 115.10M |
| Operating Income | -199.60M |
| Pretax Income | -253.50M |
| Net Income | 551.10M |
| EBITDA | -199.60M |
| EBIT | -199.60M |
| Earnings Per Share (EPS) | -6.92 |
Orexo AB holds 386.20M in cash and equivalents against 7.00M in total debt, resulting in a net debt position of -386.20M.
| Cash & Cash Equivalents | 386.20M |
| Total Debt | 7.00M |
| Net Debt | -386.20M |
| Equity (Book Value) | N/A |
| Book Value Per Share | N/A |
| Working Capital | 241.10M |
Orexo AB produced -57.60M in operating cash flow over the past twelve months. After subtracting -100,000.00 in capital expenditures, free cash flow totaled -57.70M - equivalent to -1.66 per share.
| Operating Cash Flow | -57.60M |
| Capital Expenditures | -100,000.00 |
| Free Cash Flow | -57.70M |
| FCF Per Share | -1.66 |
Orexo AB operates with a gross margin of 90.91, reflecting its pricing power and cost economics. The operating margin of -157.79 and net profit margin of 435.65 provide insight into operational efficiency.
| Gross Margin | 90.91 |
| Operating Margin | -157.79 |
| Pretax Margin | -200.40 |
| Profit Margin | 435.65 |
| EBITDA Margin | -157.79 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 63.70 |
| FCF Yield | -6.99 |
Orexo AB posts an Altman Z-Score of 1.46, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.46 |